144 related articles for article (PubMed ID: 11112412)
21. Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice.
Hoffler U; El-Masri HA; Ghanayem BI
J Pharmacol Exp Ther; 2003 May; 305(2):557-64. PubMed ID: 12704224
[TBL] [Abstract][Full Text] [Related]
22. The effect of CYP2E1-dependent oxidant stress on activity of proteasomes in HepG2 cells.
Kessova IG; Cederbaum AI
J Pharmacol Exp Ther; 2005 Oct; 315(1):304-12. PubMed ID: 16002458
[TBL] [Abstract][Full Text] [Related]
23. Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells.
Pérez MJ; Cederbaum AI
Hepatology; 2003 Jun; 37(6):1395-404. PubMed ID: 12774019
[TBL] [Abstract][Full Text] [Related]
24. Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells.
Huan JY; Streicher JM; Bleyle LA; Koop DR
Toxicol Appl Pharmacol; 2004 Sep; 199(3):332-43. PubMed ID: 15364548
[TBL] [Abstract][Full Text] [Related]
25. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration.
Donohue TM; Zetterman RK; Zhang-Gouillon ZQ; French SW
Hepatology; 1998 Aug; 28(2):486-91. PubMed ID: 9696015
[TBL] [Abstract][Full Text] [Related]
26. Chronic ethanol consumption results in atypical liver injury in copper/zinc superoxide dismutase deficient mice.
Curry-McCoy TV; Osna NA; Nanji AA; Donohue TM
Alcohol Clin Exp Res; 2010 Feb; 34(2):251-61. PubMed ID: 19951287
[TBL] [Abstract][Full Text] [Related]
27. Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo.
Osna NA; Haorah J; Krutik VM; Donohue TM
Hepatology; 2004 Sep; 40(3):574-82. PubMed ID: 15349895
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the susceptibility of wild-type and CYP2E1 knockout mice to the hepatotoxic and pneumotoxic effects of styrene and styrene oxide.
Carlson GP
Toxicol Lett; 2004 May; 150(3):335-9. PubMed ID: 15110085
[TBL] [Abstract][Full Text] [Related]
29. Role of CYP1A2 and CYP2E1 in the pentoxifylline ciprofloxacin drug interaction.
Peterson TC; Peterson MR; Wornell PA; Blanchard MG; Gonzalez FJ
Biochem Pharmacol; 2004 Jul; 68(2):395-402. PubMed ID: 15194011
[TBL] [Abstract][Full Text] [Related]
30. Influence of selected inhibitors on the metabolism of the styrene metabolite 4-vinylphenol in wild-type and CYP2E1 knockout mice.
Carlson G
J Toxicol Environ Health A; 2004 Jun; 67(12):905-9. PubMed ID: 15205034
[TBL] [Abstract][Full Text] [Related]
31. Alcohol-induced free radicals in mice: direct toxicants or signaling molecules?
Yin M; Gäbele E; Wheeler MD; Connor H; Bradford BU; Dikalova A; Rusyn I; Mason R; Thurman RG
Hepatology; 2001 Nov; 34(5):935-42. PubMed ID: 11679964
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ethanol-induced liver disease in the intragastric feeding rat model by chlormethiazole.
Gouillon Z; Lucas D; Li J; Hagbjork AL; French BA; Fu P; Fang C; Ingelman-Sundberg M; Donohue TM; French SW
Proc Soc Exp Biol Med; 2000 Sep; 224(4):302-8. PubMed ID: 10964266
[TBL] [Abstract][Full Text] [Related]
33. Role of CYP2E1 in diethylnitrosamine-induced hepatocarcinogenesis in vivo.
Kang JS; Wanibuchi H; Morimura K; Gonzalez FJ; Fukushima S
Cancer Res; 2007 Dec; 67(23):11141-6. PubMed ID: 18056438
[TBL] [Abstract][Full Text] [Related]
34. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism.
Wu H; Cai P; Clemens DL; Jerrells TR; Ansari GA; Kaphalia BS
Toxicol Appl Pharmacol; 2006 Oct; 216(2):238-47. PubMed ID: 16806343
[TBL] [Abstract][Full Text] [Related]
35. Role of cytochrome P-450 2E1 in methacrylonitrile metabolism and disposition.
Ghanayem BI; Sanders JM; Chanas B; Burka LT; Gonzalez FJ
J Pharmacol Exp Ther; 1999 May; 289(2):1054-9. PubMed ID: 10215687
[TBL] [Abstract][Full Text] [Related]
36. DLPC attenuates alcohol-induced cytotoxicity in HepG2 cells expressing CYP2E1.
Xu Y; Leo MA; Lieber CS
Alcohol Alcohol; 2005; 40(3):172-5. PubMed ID: 15753073
[TBL] [Abstract][Full Text] [Related]
37. Genetic repeat polymorphism in the regulating region of CYP2E1: frequency and relationship with enzymatic activity in alcoholics.
Plee-Gautier E; Foresto F; Ferrara R; Bodénez P; Simon B; Manno M; Berthou F; Lucas D
Alcohol Clin Exp Res; 2001 Jun; 25(6):800-4. PubMed ID: 11410713
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of bone repair in a rat model for chronic and excessive alcohol consumption.
Chakkalakal DA; Novak JR; Fritz ED; Mollner TJ; McVicker DL; Garvin KL; McGuire MH; Donohue TM
Alcohol; 2005 Jul; 36(3):201-14. PubMed ID: 16377462
[TBL] [Abstract][Full Text] [Related]
40. The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity.
Cheung C; Yu AM; Ward JM; Krausz KW; Akiyama TE; Feigenbaum L; Gonzalez FJ
Drug Metab Dispos; 2005 Mar; 33(3):449-57. PubMed ID: 15576447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
